Daniel S. Grau

Directeur Général chez Theriana Pharmaceuticals, Inc.

Profil

Daniel S.
Grau was the founder of Sojournix, Inc. (founded in 2016) where he held the title of President, Chief Executive Officer & Director.
He is currently the President, CEO, Secretary, Treasurer & Director at Theriana Pharmaceuticals, Inc., Chairman at Lusaris Therapeutics, Inc., and Director at AbCellera Boston, Inc. (since 2019).
In his former positions, he served as Vice Chairman & Chief Executive Officer at Cortria Corp., President & Chief Executive Officer at Avilar Therapeutics, Inc., and Director at Concert Pharmaceuticals, Inc. He was also a Director at Therapeutics Acquisition Corp.
and President at Nxera Pharma UK Ltd. Additionally, he worked as the Chief Operating Officer at CombinatoRx, Inc. from 2001 to 2008 and as a Management Consultant at Pharmacia Corp.
Mr. Grau completed his undergraduate degree at Davidson College and his graduate degree at Yale University.

Postes actifs de Daniel S. Grau

Sociétés	Poste	Début
Theriana Pharmaceuticals, Inc.	Directeur Général	-
AbCellera Boston, Inc.	Directeur/Membre du Conseil	02/05/2019
Lusaris Therapeutics, Inc.	Président	-

Anciens postes connus de Daniel S. Grau

Sociétés	Poste	Fin
CombinatoRx, Inc.	Directeur des opérations	06/05/2008
Avilar Therapeutics, Inc.	Directeur Général	-
THES ACQU	Directeur/Membre du Conseil	-
Sojournix, Inc.	Fondateur	-
Nxera Pharma UK Ltd.	President	-